Detalhe da pesquisa
1.
Hepatocytes direct the formation of a pro-metastatic niche in the liver.
Nature
; 567(7747): 249-252, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842658
2.
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study.
Hepatology
; 77(3): 760-773, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152015
3.
Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers.
Hepatology
; 78(3): 758-770, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999533
4.
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers.
Hepatology
; 77(6): 1943-1957, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36052732
5.
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort.
Invest New Drugs
; 42(1): 127-135, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270822
6.
Targeting Fibroblast Growth Factor Receptor Pathway: Precision Medicine for Biliary Cancer and Beyond.
Semin Liver Dis
; 43(2): 218-225, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882151
7.
Futibatinib, an Irreversible FGFR1-4 Inhibitor for the Treatment of FGFR-Aberrant Tumors.
Oncologist
; 28(11): 928-943, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390492
8.
Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma.
Oncologist
; 28(10): 917-e966, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339254
9.
CS-iCCA, A New Clinically Based Staging System for Intrahepatic Cholangiocarcinoma: Establishment and External Validation.
Am J Gastroenterol
; 118(12): 2173-2183, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36940423
10.
Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4/6 inhibitors in biliary tract cancers.
Hepatology
; 75(1): 43-58, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407567
11.
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
Gut
; 71(1): 185-193, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431577
12.
Temporal Changes in Cholangiocarcinoma Incidence and Mortality in the United States from 2001 to 2017.
Oncologist
; 27(10): 874-883, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35972334
13.
The Role of Systemic Therapy in Resectable Colorectal Liver Metastases: Systematic Review and Network Meta-Analysis.
Oncologist
; 27(12): 1034-1040, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239399
14.
Germline Cancer Susceptibility Gene Testing in Unselected Patients With Colorectal Adenocarcinoma: A Multicenter Prospective Study.
Clin Gastroenterol Hepatol
; 20(3): e508-e528, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857637
15.
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma.
Invest New Drugs
; 40(1): 81-90, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417914
16.
A pilot study of Pan-FGFR inhibitor ponatinib in patients with FGFR-altered advanced cholangiocarcinoma.
Invest New Drugs
; 40(1): 134-141, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463891
17.
FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations.
Dig Dis Sci
; 67(8): 3797-3805, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34773565
18.
Pertuzumab and trastuzumab for HER2-positive, metastatic biliary tract cancer (MyPathway): a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 22(9): 1290-1300, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339623
19.
Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
Semin Liver Dis
; 41(2): 136-141, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957697
20.
FGFR2 fusion proteins drive oncogenic transformation of mouse liver organoids towards cholangiocarcinoma.
J Hepatol
; 75(2): 351-362, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741397